
北美光学相干断层扫描血管造影设备市场预测至 2028 年 - COVID-19 影响和按类型(台式和手持式)和最终用户(医院、诊所等)进行的区域分析
No. of Pages: 114 | Report Code: BMIRE00025109 | Category: Life Sciences
No. of Pages: 114 | Report Code: BMIRE00025109 | Category: Life Sciences
该地区的市场增长归因于普及率的不断提高与眼睛相关的疾病和老年人口的增加。然而,缺乏熟练的专业人员以及与设备相关的技术挑战限制了市场的增长。
与眼睛相关的疾病和疾病包括糖尿病视网膜病变、青光眼、年龄相关性黄斑变性、眼组织胞浆菌病、视网膜静脉阻塞以及视网膜破裂和脱离。糖尿病视网膜病变 (DR) 是由于高血糖损害视网膜血管或引起视网膜血管变化而引起的。这些变化可能包括肿胀、渗漏或闭合,从而阻止血液通过。在某些人中,视网膜表面会生长出异常的新血管。视网膜的这种变化会妨碍人的视力。根据 NCBI 的文章,全球患有 DR 的成年人数量预计将从 2020 年的约 1.0312 亿增长到 2045 年的约 1.605 亿。此外,DR 是最常见的糖尿病眼病,也是美国成年人失明的主要原因。根据美国国家眼科研究所的数据,到 2050 年,美国患有 DR 的人数预计将增加一倍,从 2010 年的 770 万增加到 1,460 万。到 2040 年,预计将有超过 1.5 亿人患有糖尿病,因此,患有糖尿病的人数预计将增加一倍。预计未来糖尿病性视网膜病变和视力障碍的发病率也会上升。
青光眼是全球第二大失明原因,会损害眼睛的视神经。根据国家青光眼研究数据,美国青光眼患者人数预计将从 2020 年的约 8000 万增加到 2040 年的约 1.11 亿。它也是美国不可逆转失明的主要原因,因为超过 300 万美国人可能患有青光眼。在导致成人完全失明的各种原因中,2020年全球失明病例中,青光眼占11.0%,其次是糖尿病视网膜病变,占2.5%。
光学相干断层扫描(OCT)血管造影有助于评估各种眼科疾病,如糖尿病视网膜病变、年龄相关性黄斑变性(AMD)和视网膜血管闭塞等。通过提供视网膜脉管系统的详细视图,可以准确描绘糖尿病眼异常和血管闭塞。它有助于根据糖尿病视网膜病变的严重程度量化血管损害。 OCT 血管造影可以帮助观察微动脉瘤和视网膜无灌注区域,从而能够更仔细地观察每一层视网膜毛细血管。它还评估微血管状态和 DR 治疗的有效性。因此,眼部相关疾病患病率的上升促进了医院和影像中心采用 OCT 设备,从而推动光学相干断层扫描血管造影设备市场的增长。
  ;
北美光学相干断层扫描血管造影设备市场细分
北美光学相干断层扫描血管造影设备市场根据类型,分为手持式和桌面式。该市场根据最终用户分为医院、诊所等。从国家来看,北美光学相干断层扫描血管造影设备市场分为美国、加拿大和墨西哥。
NIDEK CO.;有限公司,卡尔蔡司股份公司;奥普托公司;佳能公司; OPTOPOL 科技有限公司动物园;迈克尔逊诊断有限公司;桑泰克公司;爱尔康公司;拓普康公司;和海德堡工程有限公司是
北美光学相干断层扫描血管造影设备市场的领先公司之一。
Strategic insights for North America Optical Coherence Tomography Angiography Equipment involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 223.74 Million |
Market Size by 2028 | US$ 360.54 Million |
Global CAGR (2021 - 2028) | 7.1% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By 类型
|
Regions and Countries Covered | 北美
|
Market leaders and key company profiles |
The regional scope of North America Optical Coherence Tomography Angiography Equipment refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The North America Optical Coherence Tomography Angiography Equipment Market is valued at US$ 223.74 Million in 2021, it is projected to reach US$ 360.54 Million by 2028.
As per our report North America Optical Coherence Tomography Angiography Equipment Market, the market size is valued at US$ 223.74 Million in 2021, projecting it to reach US$ 360.54 Million by 2028. This translates to a CAGR of approximately 7.1% during the forecast period.
The North America Optical Coherence Tomography Angiography Equipment Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Optical Coherence Tomography Angiography Equipment Market report:
The North America Optical Coherence Tomography Angiography Equipment Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Optical Coherence Tomography Angiography Equipment Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Optical Coherence Tomography Angiography Equipment Market value chain can benefit from the information contained in a comprehensive market report.